Zura Bio Ltd SEC filings ZURA

Zura Bio Ltd has 446 filings in SEC EDGAR's recent list, going back to Apr 8, 2021. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 27, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 27, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.

Form Description Filed Period
DEFA14A Additional proxy material May 22, 2026 —
DEF 14A Proxy statement Apr 30, 2026 Jun 17, 2026
DEF 14A Proxy statement Apr 23, 2025 May 21, 2025
DEFA14A Additional proxy material Sep 13, 2024 —
DEF 14A Proxy statement Sep 13, 2024 Oct 23, 2024
DEF 14A Proxy statement May 19, 2023 Jun 1, 2023
PRE 14A Preliminary proxy statement May 9, 2023 May 8, 2023
DEF 14A Proxy statement Dec 6, 2022 Jan 12, 2023
PRE 14A Preliminary proxy statement Nov 23, 2022 Nov 23, 2022

Showing 9 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
ZURA (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Cayman Islands
Headquarters
La Jolla, CA
SEC filer status
, Emerging growth company
SEC CIK
1855644
Former names
JATT Acquisition Corp (until Mar 21, 2023)

Other Biological Products, (No Diagnostic Substances) companies

All 182 Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.